World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
117
Citations
51568
World Ranking
288
National Ranking
172

Medicine

D-Index
118
Citations
52665
World Ranking
4051
National Ranking
2218

Joseph R. Testa publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Joseph R. Testa sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 398 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Joseph R. Testa D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Joseph R. Testa sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 117 D-Index — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2011 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Joseph R. Testa is affiliated with the Fox Chase Cancer Center in the United States. Their research primarily focuses on the fields of medicine and biochemistry, genetics, and molecular biology, with published work also spanning several related subfields.

The main subfields of study for Testa include pulmonary and respiratory medicine, molecular biology, cancer research, oncology, and hematology. Their research topics reflect these areas, covering subjects such as occupational and environmental lung diseases, medical imaging and pathology studies, DNA repair mechanisms, pleural and pulmonary diseases, renal cell carcinoma treatment, carcinogens and genotoxicity assessment, as well as interstitial lung diseases and idiopathic pulmonary fibrosis.

Testa has contributed to several frequent publication venues, including Cancer Genetics, Cancers, bioRxiv (Cold Spring Harbor Laboratory), Cancer Research, and Molecular Cell. They often collaborate with a consistent group of co-authors, among whom are Eleonora Sementino, Yuwaraj Kadariya, Jianming Pei, Mitchell Cheung, and Kathy Q. Cai.

Recent papers attributable to Testa include the following:

  • The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells, 2022, Science Signaling
  • Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma, 2020, Clinical Cancer Research
  • BRCA1 Mutational Complementation Induces Synthetic Viability, 2020, Molecular Cell
  • DLX Genes: Roles in Development and Cancer, 2021, Cancers
  • Asbestos and Other Hazardous Fibrous Minerals: Potential Exposure Pathways and Associated Health Risks, 2022, International Journal of Environmental Research and Public Health

Joseph R. Testa has been recognized as a Fellow of the American Association for the Advancement of Science (AAAS), receiving this distinction in 2011.

Best Publications

  • Integrated genomic analyses of ovarian carcinoma

    D. Bell;A. Berchuck;M. Birrer;J. Chien

  • Perturbations of the AKT signaling pathway in human cancer

    Deborah A Altomare;Joseph R Testa

  • A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region

    A Bellacosa;Testa;SP Staal;PN Tsichlis

  • AKT plays a central role in tumorigenesis.

    Joseph R. Testa;Alfonso Bellacosa

  • Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.

    A. Bellacosa;D. De Feo;A. K. Godwin;D. W. Bell

  • Germline BAP1 mutations predispose to malignant mesothelioma

    Joseph R Testa;Mitchell Cheung;Jianming Pei;Jennifer E Below

  • Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA

    Jin Quan Cheng;Bruce Ruggeri;Walter M. Klein;Gonosuke Sonoda

  • Activation of AKT kinases in cancer: implications for therapeutic targeting.

    Alfonso Bellacosa;C. Chandra Kumar;Antonio Di Cristofano;Joseph Robert Testa

  • AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.

    Jin Quan Cheng;Andrew K. Godwin;Alfonso Bellacosa;Takahiro Taguchi

  • BAP1 and cancer

    Michele Carbone;Haining Yang;Harvey I. Pass;Thomas Krausz

  • Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E.

    Andrew C. Hsieh;Maria Costa;Ornella Zollo;Cole Davis

  • Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways

    Guang-Hui Xiao;Michael Jeffers;Alfonso Bellacosa;Yasuhiro Mitsuuchi

  • AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth

    Deborah A Altomare;Hui Qin Wang;Kristine L Skele;Assunta De Rienzo

  • The pathogenesis of mesothelioma

    Michele Carbone;Robert A. Kratzke;Joseph R. Testa;Joseph R. Testa;Joseph R. Testa

  • Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas

    Bruce A. Ruggeri;Lingyi Huang;Moira Wood;Jin Quan Cheng

  • High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas

    Albert B. Bianchi;Shin-Ichiro Mitsunaga;Jin Quan Cheng;Walter M. Klein

  • Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene

    Raymond S. Yeung;Guang-Hui Xiao;Fang Jin;Wen-Ching Lee

  • p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma.

    Jin Quan Cheng;Suresh C. Jhanwar;Walter M. Klein;Daphne W. Bell

  • Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia.

    Charles A. Schiffer;Edward J. Lee;Takafumi Tomiyasu;Peter H. Wiernik

  • Integrated genomic analyses of ovarian carcinoma

    D. Bell;A. Berchuck;M. Birrer;J. Chien

Frequent Co-Authors

Suresh C. Jhanwar
Suresh C. Jhanwar Memorial Sloan Kettering Cancer Center
Michele Carbone
Michele Carbone University of Hawaii at Manoa
Andres J. P. Klein-Szanto
Andres J. P. Klein-Szanto Fox Chase Cancer Center
Robert G. Uzzo
Robert G. Uzzo Fox Chase Cancer Center
Harvey I. Pass
Harvey I. Pass New York University
Alfonso Bellacosa
Alfonso Bellacosa Fox Chase Cancer Center
Jill M. Siegfried
Jill M. Siegfried University of Minnesota
David L. Wiest
David L. Wiest Fox Chase Cancer Center
Thomas C. Hamilton
Thomas C. Hamilton Fox Chase Cancer Center
Nancy A. Jenkins
Nancy A. Jenkins The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Molecular Biology, there are several related online programs and career paths worth exploring. Many choose interdisciplinary degrees, such as online clinical psychology programs, to bridge the gap between biological sciences and mental health. These programs can be a strong option for those fascinated by how biological factors affect behavior.

Another growing field is human services. Pursuing a human services degree online allows students to quickly gain the credentials needed to support individuals and communities, including roles that overlap with healthcare or laboratory management.

Changing careers with a biosciences foundation is also possible. For example, students who have a background in education can leverage resources on teacher to slp for transitioning into speech-language pathology—a field closely connected to neurology and genetics.

Finally, those with an interest in both biology and design may consider programs like the best online architecture degree, combining scientific knowledge with creativity in fields like bio-architecture and sustainable design. Exploring these pathways can help shape a flexible, rewarding career after studying Molecular Biology.

Best Scientists Citing Joseph R. Testa

Trending Scientists

Recently Published Articles